Varicella-zoster virus expressing HSV-2 glycoproteins B and D induces protection against HSV-2 challenge

This publication has 31 references indexed in Scilit:

• Herpes Simplex Virus (HSV) Type 2 Glycoprotein D Subunit Vaccines and Protection against Genital HSV‐1 or HSV‐2 Disease in Guinea Pigs
  The Journal of Infectious Diseases, 2003
• Vaccine-Induced Serum Immunoglobin Contributes to Protection from Herpes Simplex Virus Type 2 Genital Infection in the Presence of Immune T Cells
  Journal of Virology, 2001
• A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 Disease
  The Journal of Infectious Diseases, 1997
• Efficacy Of High-Titer Live Attenuated Varicella Vaccine In Healthy Young Children
  The Journal of Infectious Diseases, 1996
• Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: protection studies against lethal viral infection in mice
  Journal of General Virology, 1995
• Baculovirus expressed herpes simplex virus type 1 glycoprotein C protects mice from lethal HSV-1 infection
  Antiviral Research, 1992
• Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B.
  Journal of Clinical Investigation, 1990
• Preinfection Prophylaxis with Herpes Simplex Virus Glycoprotein Immunogens: Factors Influencing Efficacy
  Journal of General Virology, 1989
• Vaccination with Recombinant Herpes Simplex Virus Glycoproteins: Protection Against Initial and Recurrent Genital Herpes
  The Journal of Infectious Diseases, 1987
• Acute and latent herpes simplex virus neurological disease in mice immunized with purified virus‐specific glycoproteins gB or gD
  Journal of Medical Virology, 1985